Your browser is no longer supported. Please, upgrade your browser.
Settings
AVGR Avinger, Inc. daily Stock Chart
AVGR [NASD]
Avinger, Inc.
Index- P/E- EPS (ttm)-38.74 Insider Own0.10% Shs Outstand17.59M Perf Week3.38%
Market Cap5.27M Forward P/E- EPS next Y-1.04 Insider Trans0.00% Shs Float15.07M Perf Month-73.47%
Income-43.10M PEG- EPS next Q-0.51 Inst Own5.70% Short Float12.28% Perf Quarter-73.93%
Sales7.90M P/S0.67 EPS this Y44.80% Inst Trans154.07% Short Ratio3.34 Perf Half Y-77.71%
Book/sh0.98 P/B0.31 EPS next Y85.60% ROA-217.70% Target Price3.25 Perf Year-96.80%
Cash/sh0.57 P/C0.52 EPS next 5Y- ROE392.90% 52W Range0.27 - 11.96 Perf YTD-95.88%
Dividend- P/FCF- EPS past 5Y11.50% ROI-472.80% 52W High-97.49% Beta2.00
Dividend %- Quick Ratio1.00 Sales past 5Y3.00% Gross Margin-9.40% 52W Low11.04% ATR0.07
Employees65 Current Ratio1.30 Sales Q/Q-16.00% Oper. Margin- RSI (14)20.17 Volatility7.96% 13.95%
OptionableNo Debt/Eq1.18 EPS Q/Q95.40% Profit Margin- Rel Volume0.76 Prev Close0.31
ShortableYes LT Debt/Eq0.00 EarningsNov 15 AMC Payout- Avg Volume553.98K Price0.30
Recom1.00 SMA20-39.08% SMA50-69.89% SMA200-78.89% Volume418,827 Change-1.83%
Mar-09-18Initiated Ladenburg Thalmann Buy
Apr-12-17Downgrade Oppenheimer Outperform → Perform
Apr-11-17Downgrade Canaccord Genuity Buy → Hold $4.30 → $1
Dec-29-15Downgrade Dougherty & Company Buy → Neutral
May-08-15Reiterated Dougherty & Company Buy $16 → $18
Apr-29-15Initiated Dougherty & Company Buy $16
Feb-24-15Initiated Oppenheimer Outperform $15
Feb-24-15Initiated Canaccord Genuity Buy $18
Nov-15-18 08:55AM  Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels ACCESSWIRE
Nov-14-18 02:22PM  Avinger: 3Q Earnings Snapshot Associated Press
07:21AM  Edited Transcript of AVGR earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-18 03:01PM  Avinger Provides Third Quarter 2018 Shareholder Update ACCESSWIRE
Nov-07-18 07:45AM  Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018 ACCESSWIRE
Nov-05-18 06:30AM  Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018 ACCESSWIRE
Nov-01-18 04:05PM  Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option ACCESSWIRE
Oct-30-18 08:30AM  Avinger Announces Pricing of $10 Million Underwritten Public Offering ACCESSWIRE -44.58%
Oct-18-18 08:30AM  Avinger Receives CE Marking Approval for Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels ACCESSWIRE
Sep-05-18 08:30AM  Avinger Announces Successful Treatment of 200th Patient with Next-Generation Pantheris Device ACCESSWIRE
Aug-30-18 08:30AM  Avinger Announces 510(k) Filing of Pantheris Small Vessel Device GlobeNewswire
Aug-29-18 03:50PM  Edited Transcript of AVGR earnings conference call or presentation 13-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
08:30AM  Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System GlobeNewswire
Aug-28-18 08:30AM  Avinger Announces Participation in Upcoming Investor Conferences GlobeNewswire +5.00%
Aug-23-18 08:30AM  Avinger Completes Enrollment in SCAN Clinical Study GlobeNewswire
Aug-13-18 04:07PM  Avinger: 2Q Earnings Snapshot Associated Press +9.40%
04:00PM  Avinger Announces Second Quarter 2018 Financial Results GlobeNewswire
03:00PM  Avinger, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 10:30AM  Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018 GlobeNewswire
Jul-24-18 07:45AM  Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks ACCESSWIRE
Jul-12-18 08:30AM  Avinger Announces Pricing of $3.55 Million Registered Direct Offering GlobeNewswire -6.33%
Jul-10-18 08:30AM  Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer GlobeNewswire -5.33%
Jun-27-18 08:00AM  Todays Research Reports on Stocks to Watch: Achaogen and Avinger ACCESSWIRE
07:10AM  Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities ACCESSWIRE
Jun-26-18 08:30AM  Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US GlobeNewswire +16.11%
Jun-25-18 10:24AM  Avinger Inc (NASDAQ:AVGR): Is Breakeven Near? Simply Wall St.
Jun-21-18 08:30AM  Avingers Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018 GlobeNewswire
Jun-14-18 08:30AM  Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound GlobeNewswire
Jun-13-18 08:30AM  Avinger Appoints Mark Weinswig as Chief Financial Officer GlobeNewswire
Jun-11-18 06:36PM  Loss-Making Avinger Inc (NASDAQ:AVGR) Expected To Breakeven Simply Wall St. +7.19%
May-30-18 08:30AM  Avinger Announces Presentations and Posters Featuring Lumivascular Technology at New Cardiovascular Horizons Annual Conference GlobeNewswire -8.81%
May-29-18 08:30AM  Avinger to Present at the 8th Annual LD Micro Invitational GlobeNewswire
07:30AM  Complimentary Technical Snapshots on Avinger and Three More Medical Equipment Stocks ACCESSWIRE
May-24-18 08:00AM  Todays Research Reports on Stocks to Watch: Avinger and Cara Therapeutics ACCESSWIRE -11.66%
May-23-18 01:20PM  Avinger Inc Stock Goes Gangbusters on FDA Approval of Next-Gen Medical Device InvestorPlace +72.87%
08:30AM  Avinger Receives FDA Clearance of Next Generation Pantheris Device GlobeNewswire
May-22-18 01:07PM  What Investors Should Know About Avinger Incs (NASDAQ:AVGR) Financial Strength Simply Wall St.
May-20-18 07:42AM  Edited Transcript of AVGR earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:54PM  Avinger: 1Q Earnings Snapshot Associated Press
04:15PM  Avinger Announces First Quarter 2018 Financial Results GlobeNewswire
12:15PM  Avinger, Inc. to Host Earnings Call ACCESSWIRE
May-04-18 08:00AM  Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018 GlobeNewswire
May-02-18 08:10AM  Todays Research Reports on Stocks to Watch: Avinger and VIVUS ACCESSWIRE
Apr-30-18 08:30AM  Avingers Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018 GlobeNewswire
Mar-29-18 09:50AM  2 Emerging Technology Stocks That Could Spark New Industry Trends ACCESSWIRE +14.66%
09:00AM  Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris GlobeNewswire
07:30AM  Blog Exposure - InspireMD Announced Regulatory Approval for CGuard Embolic Prevention System and MGuard Prime in Peru ACCESSWIRE
Mar-21-18 08:00AM  Avinger Enters into Settlement Agreement for All Outstanding Securities Class Action Litigation GlobeNewswire +10.53%
Mar-20-18 09:11AM  Edited Transcript of AVGR earnings conference call or presentation 19-Mar-18 8:30pm GMT Thomson Reuters StreetEvents -17.99%
Mar-19-18 04:20PM  Avinger reports 4Q loss Associated Press +16.81%
04:01PM  Avinger Announces Fourth Quarter and Full Year 2017 Results GlobeNewswire
12:00PM  Avinger, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 08:00AM  Avinger Provides Update on U.S. Intellectual Property Portfolio GlobeNewswire
Mar-06-18 08:00AM  Avinger to Announce Fourth Quarter 2017 and Full Year 2017 Results on March 19th, 2018 GlobeNewswire
Mar-05-18 08:00AM  Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-02-18 08:00AM  Avinger Regains Compliance with Nasdaq Listing Requirements GlobeNewswire +18.35%
Feb-20-18 08:00AM  OPS Code Established for Peripheral Vascular OCT Imaging in Germany GlobeNewswire +12.78%
Feb-16-18 01:30PM  Avinger Announces Closing of $18 Million Underwritten Public Offering GlobeNewswire -11.33%
Feb-14-18 08:30AM  Avinger Announces Pricing of $18 Million Underwritten Public Offering GlobeNewswire -41.42%
Feb-02-18 08:00AM  Avingers Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018 GlobeNewswire
Jan-30-18 04:45PM  Avinger Announces Reverse Stock Split GlobeNewswire
Jan-22-18 10:50AM  Does Avinger Incs (NASDAQ:AVGR) Past Performance Indicate A Stronger Future? Simply Wall St.
Jan-19-18 09:05AM  Did Avinger Incs (NASDAQ:AVGR) Recent Earnings Growth Beat The Trend? Simply Wall St.
08:00AM  Avinger Granted Continued Listing Decision From Nasdaq GlobeNewswire
Jan-03-18 08:30AM  Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris GlobeNewswire
Jan-02-18 11:39AM  What Should You Know About The Future Of Avinger Incs (NASDAQ:AVGR) Business? Simply Wall St.
Dec-21-17 08:30AM  Avinger Announces 510(k) Filing of Next Generation Pantheris Device GlobeNewswire
Dec-20-17 08:30AM  Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device GlobeNewswire
Dec-14-17 04:01PM  Avinger Secures Waiver and Consent to CRG Loan Agreement GlobeNewswire
Dec-11-17 04:15PM  Avinger Announces Change in Board Leadership GlobeNewswire
Nov-21-17 09:06AM  Avinger, Inc. :AVGR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017 Capital Cube
Nov-14-17 03:53PM  Edited Transcript of AVGR earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents -5.28%
Nov-09-17 05:07PM  Avinger reports 3Q loss Associated Press
04:01PM  Avinger Announces Third Quarter 2017 Results GlobeNewswire
12:45PM  Why Avinger Incs (AVGR) Investor Composition Impacts Your Returns Simply Wall St.
Nov-08-17 05:38PM  ETFs with exposure to Avinger, Inc. : November 8, 2017 Capital Cube
Nov-06-17 07:30AM  Avinger Enters into Common Stock Purchase Agreement for up to $15.0 Million with Lincoln Park Capital GlobeNewswire -5.22%
Oct-31-17 04:01PM  Avinger Receives 510(k) Clearance for Design Modifications to Enhance Performance of Pantheris Image-Guided Atherectomy Device GlobeNewswire
08:00AM  Avinger to Announce Third Quarter 2017 Results on November 9, 2017 GlobeNewswire
Oct-19-17 04:01PM  Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis GlobeNewswire -5.66%
Oct-17-17 10:48AM  Edited Transcript of AVGR earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
Oct-11-17 11:12AM  ETFs with exposure to Avinger, Inc. : October 11, 2017 Capital Cube +9.30%
Sep-28-17 10:09AM  ETFs with exposure to Avinger, Inc. : September 28, 2017 Capital Cube -17.41%
Sep-26-17 04:01PM  Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy GlobeNewswire -9.13%
Sep-05-17 10:11AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017 ACCESSWIRE
Sep-01-17 11:50PM  INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Avinger, Inc. GlobeNewswire
10:03AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017 ACCESSWIRE
Aug-30-17 04:28PM  6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
03:08PM  Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming September 5th Deadline for Lead Plaintiff Motions in Securities Class Action Against Avinger, Inc. (AVGR) Business Wire
Aug-29-17 12:48PM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE +6.10%
10:02AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017 ACCESSWIRE
Aug-25-17 03:52PM  ETFs with exposure to Avinger, Inc. : August 25, 2017 Capital Cube
Aug-24-17 05:52PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
10:28AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017 ACCESSWIRE
Aug-23-17 06:47PM  Lawsuit for Investors in Avinger Inc (NASDAQ:AVGR) announced by Shareholders Foundation GlobeNewswire
02:46PM  APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm PR Newswire
Aug-22-17 07:47PM  EQUITY ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Avinger, Inc. PR Newswire
04:00PM  AVGR Investors Deadline Reminder: Hagens Berman Reminds Investors in Avinger, Inc. of the September 5, 2017 Lead Plaintiff Deadline in the Pending Securities Class Action GlobeNewswire
12:14PM  AVINGER LOSS NOTICE: Rosen Law Firm Reminds Avinger, Inc. Investors of Important Deadline in Class Action Business Wire
Aug-16-17 10:50AM  Avinger, Inc. :AVGR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel HimanshuCTOFeb 16Buy1000.005050,00050Mar 05 08:30 PM